Clinical Trials Resource Center

Therapeutic Areas: Hematology | Oncology | Dermatology

Sezary Syndrome Clinical Trials

A listing of Sezary Syndrome medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Duarte California 91010

A clinical research study of romidepsin, lenalidomide and laboratory biomarker analysis, in treating patients with previously untreated Peripheral T-Cell Lymphoma

Stanford California 94305

Patients are needed to participate in a clinical research study of NM-IL-12 to evaluate Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides or Sézary Syndrome, Total Skin Electron Beam Therapy (TSEBT)

Illinois

Chicago Illinois 60611

A clinical research study of romidepsin, lenalidomide and laboratory biomarker analysis, in treating patients with previously untreated Peripheral T-Cell Lymphoma

Chicago Illinois 60611

A Phase 1 clinical study for patients using carfilzomib, romidepsin and laboratory biomarker analysis

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

New York

New York New York 10021

A clinical research study of romidepsin, lenalidomide and laboratory biomarker analysis, in treating patients with previously untreated Peripheral T-Cell Lymphoma

New York New York 10032

Patients are needed to participate in a clinical research study of NM-IL-12 to evaluate Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides or Sézary Syndrome, Total Skin Electron Beam Therapy (TSEBT)

Pennsylvania

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of NM-IL-12 to evaluate Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides or Sézary Syndrome, Total Skin Electron Beam Therapy (TSEBT)

Texas

Houston Texas 77030

A Phase 1 clinical study for patients with Leukemia

Virginia

Richmond Virginia 23298

Patients are needed to participate in a clinical research study evaluating TSEB Therapy and Brentuximab vedotin for the treatment of Mycosis Fungoides or Sézary Syndrome

Austria

Graz

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Wien

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Belgium

Brussels

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Leuven

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

France

Bordeaux

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Clermont-Ferrand

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Lyon

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Germany

Berlin

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Bochum

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Buxtehude

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Cologne

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Dortmund

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Erfurt

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Essen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Gera

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Karlsruhe

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Kiel

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Krefeld

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Lübeck

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Ludwigshafen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Mainz

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Mannheim

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Minden

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Munich

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Tübingen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Ulm

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Würzburg

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Italy

Bologna

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Milano

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Netherlands

Leiden

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Poland

Bydgoszcz

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Gdansk

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Kraków

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Łódź

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Warsaw

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Wrocław

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Spain

Barcelona

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Barcelona

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous